All press releases

NEW YORK/COPENHAGEN, 18 January 2022,  – UNICEF has signed several long term agreements (LTA) with suppliers for the procurement of the new antiviral medicine Molnupiravir.   UNICEF procurement of Molnupiravir is dependent on clinical recommendations, regulatory approvals and compliance with UNICEF quality assurance requirements. In December, the US Food and drug administration issued…

NEW YORK/COPENHAGEN,, 7 December 2021, – UNICEF and Clover Biopharmaceuticals Ltd. have signed a long-term agreement for the supply of the Clover COVID-19 vaccine on behalf of the COVAX Facility. Through the supply agreement, UNICEF will have access to up to 414 million doses of Clover’s COVID-19 vaccine until the end of 2022. These doses were committed to the COVAX Facility through an…, About the COVAX Facility,   COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. COVAX  is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO. Its aim is to accelerate…

PORT-AU-PRINCE / PANAMA CITY, 20 August 2021 –, In response to the powerful earthquake that struck Haiti last week, the first UNICEF shipment of 9.7 tonnes of medical and water and hygiene supplies has arrived today in Port Au Prince.  Other flights containing 30 metric tonnes of lifesaving supplies are expected to land in the coming days before being delivered to the southern departments worst…

ADDIS ABABA/NEW YORK, 2 August 2021 –, Having secured access to up to 400 million doses of the J&J COVID-19 vaccine, the African Union (AU), African Vaccine Acquisition Trust (AVAT) and UNICEF are partnering to ensure the seamless procurement and delivery of vaccines to AU Member States. This partnership will help ramp up efforts to mitigate the impact of the pandemic as less than…

NEW YORK/COPENHAGEN 26 July 2021 - , UNICEF and Sinovac have signed a long-term agreement for the supply of the CoronaVac inactivated virus vaccine against COVID-19 on behalf of the COVAX Facility. Through the supply agreement, UNICEF will have access to up to 200 million doses of the vaccine in 2021 to supply participating countries and territories in the COVAX Facility’s Advance…

NEW YORK/COPENHAGEN, 12 July 2021 - , UNICEF and Sinopharm have signed a long-term agreement for the supply of the BBIBP-CorV inactivated virus vaccine against COVID-19 on behalf of the COVAX Facility.    Through the agreement, UNICEF will have access to up to 120 million doses of the vaccine by the end of 2021 to supply participating countries and territories in the COVAX Facility’s…

NEW YORK, 8 July 2021 – , UNICEF has signed an agreement with Janssen Pharmaceutica NV to supply up to 220 million doses of the J&J single-dose vaccine for all 55 Member States of the African Union (AU) by the end of 2022. Some 35 million doses are to be delivered by the end of this year. The agreement between UNICEF and Janssen Pharmaceutica NV will help implement the…

COPENHAGEN/NEW YORK, 1 July 2021 –, UNICEF has signed a long-term agreement with Janssen Pharmaceutica NV for the supply of COVID-19 vaccines on behalf of the COVAX Facility.   Through the supply agreement, UNICEF, along with procurement partners including the Pan-American Health Organization (PAHO), will have access to up to 200 million doses of the single-dose vaccine in 2021 for…

GENEVA/NEW YORK/OSLO, 1 July 2021 –,  "COVAX was built on the principle of equitable access to COVID-19 vaccines to protect the health of people all across the globe. That means protecting their lives and livelihoods, including their ability to travel and conduct trade. As travel and other possibilities begin to open up in some parts of the world, COVAX urges all regional, national…

NEW YORK/COPENHAGEN, 3 JUNE 2021, – UNICEF’s global procurement and supply operations grew by 17 per cent in 2020 to reach a record US$4.468 billion, underscoring the organization’s role in supporting governments’ response to the COVID-19 pandemic.   Global demand for medical supplies surged early last year, as borders were closing, export bans were being imposed and international…

COPENHAGEN/NEW YORK, 2 June 2021 –, UNICEF has signed a long-term agreement with Moderna for the supply of COVID-19 vaccine on behalf of the COVAX Facility.   Through the supply agreement, UNICEF, along with procurement partners including the Pan American Health Organization (PAHO), will have access to up to 34 million doses of the vaccine for around 92 countries and territories in…

NEW YORK/COPENHAGEN, 27 May 2021 - ,  UNICEF and Human Vaccine (Limited Liability Company), a wholly-owned subsidiary of the Russian Direct Investment Fund (RDIF), today announced a long-term agreement (LTA) for the supply of the Sputnik V COVID-19 vaccine. This is the fourth long-term supply agreement UNICEF has signed with a COVID-19 vaccine manufacturer. So far this year, UNICEF…